Comparison of 18F-AIF-NOTA-PRGD2 and 18F-FDG uptake in lymph node metastasis of differentiated thyroid cancer.

A widespread application of integrin αvβ3 imaging has been emerging in both pre-clinical and clinical studies. But few studies reported its value as compared with 18F-FDG PET, especially for differentiated thyroid cancer (DTC). In this study, we compared the tracer uptake of 18F-AIF-NOTA-PRGD2 and 1...

Full description

Bibliographic Details
Main Authors: Weiwei Cheng, Zhenyu Wu, Sheng Liang, Hongliang Fu, Shuqi Wu, Yiyun Tang, Zhiyi Ye, Hui Wang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4067334?pdf=render
id doaj-258f911b72084f1d85b78f23d6ae629a
record_format Article
spelling doaj-258f911b72084f1d85b78f23d6ae629a2020-11-24T23:51:06ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0196e10052110.1371/journal.pone.0100521Comparison of 18F-AIF-NOTA-PRGD2 and 18F-FDG uptake in lymph node metastasis of differentiated thyroid cancer.Weiwei ChengZhenyu WuSheng LiangHongliang FuShuqi WuYiyun TangZhiyi YeHui WangA widespread application of integrin αvβ3 imaging has been emerging in both pre-clinical and clinical studies. But few studies reported its value as compared with 18F-FDG PET, especially for differentiated thyroid cancer (DTC). In this study, we compared the tracer uptake of 18F-AIF-NOTA-PRGD2 and 18F-FDG in lymph node metastasis of DTC to evaluate 18F-AIF-NOTA-PRGD2 as compared with 18F-FDG.20 DTC patients with presumptive lymph node metastasis were examined with 18F-AIF-NOTA-PRGD2 and 18F-FDG PET/CT. 16 patients undergoing fine needle aspiration biopsy (FNAB) were evaluated by cytology results. For lesions without FNAB, the findings of clinical staging procedures served as the standard of reference (including neck ultrasound and serum thyroglobulin).A total of 39 presumptive lymph node metastases were visualized on PET/CT images. 35 lesions were confirmed as malignant by FNAB and other clinical findings. The mean 18F-AIF-NOTA-PRGD2 in radioactive iodine-refractory (RAIR) lesions and benign lesions were 2.5±0.9 and 2.8±0.9 respectively. The mean SUV for 18F-FDG in all malignant lesions was 4.5±1.6 while in benign lesions it was 3.3±1.2. For all malignant lesions, the mean SUV for 18F-FDG was significantly higher than that for 18F-AIF-NOTA-PRGD2 (P<0.05). No significant correlation was found between the SUVs of 18F-AIF-NOTA-PRGD2 and 18F-FDG for 35 lesions (r = 0.114, P = 0.515). Moreover, 15 lesions of which the diameter larger than 1.5 cm had higher 18F-AIF-NOTA-PRGD2 uptake as compared with the lesions smaller than 1.5 cm.Although most lymph node metastases of DTC showed abnormal uptake of 18F-AIF-NOTA-PRGD2, its diagnostic value was inferior to 18F-FDG. No correlation was found between the uptake of 18F-AIF-NOTA-PRGD2 and 18F-FDG, which may suggest the two tracers provide complementary information in DTC lesions.http://europepmc.org/articles/PMC4067334?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Weiwei Cheng
Zhenyu Wu
Sheng Liang
Hongliang Fu
Shuqi Wu
Yiyun Tang
Zhiyi Ye
Hui Wang
spellingShingle Weiwei Cheng
Zhenyu Wu
Sheng Liang
Hongliang Fu
Shuqi Wu
Yiyun Tang
Zhiyi Ye
Hui Wang
Comparison of 18F-AIF-NOTA-PRGD2 and 18F-FDG uptake in lymph node metastasis of differentiated thyroid cancer.
PLoS ONE
author_facet Weiwei Cheng
Zhenyu Wu
Sheng Liang
Hongliang Fu
Shuqi Wu
Yiyun Tang
Zhiyi Ye
Hui Wang
author_sort Weiwei Cheng
title Comparison of 18F-AIF-NOTA-PRGD2 and 18F-FDG uptake in lymph node metastasis of differentiated thyroid cancer.
title_short Comparison of 18F-AIF-NOTA-PRGD2 and 18F-FDG uptake in lymph node metastasis of differentiated thyroid cancer.
title_full Comparison of 18F-AIF-NOTA-PRGD2 and 18F-FDG uptake in lymph node metastasis of differentiated thyroid cancer.
title_fullStr Comparison of 18F-AIF-NOTA-PRGD2 and 18F-FDG uptake in lymph node metastasis of differentiated thyroid cancer.
title_full_unstemmed Comparison of 18F-AIF-NOTA-PRGD2 and 18F-FDG uptake in lymph node metastasis of differentiated thyroid cancer.
title_sort comparison of 18f-aif-nota-prgd2 and 18f-fdg uptake in lymph node metastasis of differentiated thyroid cancer.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description A widespread application of integrin αvβ3 imaging has been emerging in both pre-clinical and clinical studies. But few studies reported its value as compared with 18F-FDG PET, especially for differentiated thyroid cancer (DTC). In this study, we compared the tracer uptake of 18F-AIF-NOTA-PRGD2 and 18F-FDG in lymph node metastasis of DTC to evaluate 18F-AIF-NOTA-PRGD2 as compared with 18F-FDG.20 DTC patients with presumptive lymph node metastasis were examined with 18F-AIF-NOTA-PRGD2 and 18F-FDG PET/CT. 16 patients undergoing fine needle aspiration biopsy (FNAB) were evaluated by cytology results. For lesions without FNAB, the findings of clinical staging procedures served as the standard of reference (including neck ultrasound and serum thyroglobulin).A total of 39 presumptive lymph node metastases were visualized on PET/CT images. 35 lesions were confirmed as malignant by FNAB and other clinical findings. The mean 18F-AIF-NOTA-PRGD2 in radioactive iodine-refractory (RAIR) lesions and benign lesions were 2.5±0.9 and 2.8±0.9 respectively. The mean SUV for 18F-FDG in all malignant lesions was 4.5±1.6 while in benign lesions it was 3.3±1.2. For all malignant lesions, the mean SUV for 18F-FDG was significantly higher than that for 18F-AIF-NOTA-PRGD2 (P<0.05). No significant correlation was found between the SUVs of 18F-AIF-NOTA-PRGD2 and 18F-FDG for 35 lesions (r = 0.114, P = 0.515). Moreover, 15 lesions of which the diameter larger than 1.5 cm had higher 18F-AIF-NOTA-PRGD2 uptake as compared with the lesions smaller than 1.5 cm.Although most lymph node metastases of DTC showed abnormal uptake of 18F-AIF-NOTA-PRGD2, its diagnostic value was inferior to 18F-FDG. No correlation was found between the uptake of 18F-AIF-NOTA-PRGD2 and 18F-FDG, which may suggest the two tracers provide complementary information in DTC lesions.
url http://europepmc.org/articles/PMC4067334?pdf=render
work_keys_str_mv AT weiweicheng comparisonof18faifnotaprgd2and18ffdguptakeinlymphnodemetastasisofdifferentiatedthyroidcancer
AT zhenyuwu comparisonof18faifnotaprgd2and18ffdguptakeinlymphnodemetastasisofdifferentiatedthyroidcancer
AT shengliang comparisonof18faifnotaprgd2and18ffdguptakeinlymphnodemetastasisofdifferentiatedthyroidcancer
AT hongliangfu comparisonof18faifnotaprgd2and18ffdguptakeinlymphnodemetastasisofdifferentiatedthyroidcancer
AT shuqiwu comparisonof18faifnotaprgd2and18ffdguptakeinlymphnodemetastasisofdifferentiatedthyroidcancer
AT yiyuntang comparisonof18faifnotaprgd2and18ffdguptakeinlymphnodemetastasisofdifferentiatedthyroidcancer
AT zhiyiye comparisonof18faifnotaprgd2and18ffdguptakeinlymphnodemetastasisofdifferentiatedthyroidcancer
AT huiwang comparisonof18faifnotaprgd2and18ffdguptakeinlymphnodemetastasisofdifferentiatedthyroidcancer
_version_ 1725477499009236992